Basic Information
FESPIXON CREAM
CREAM
Regulatory Information
SIN16683P
January 31, 2023
Prescription Only
Therapeutic
TOPICAL
August 10, 2023
June 4, 2025
Company Information
Active Ingredients
Plectranthus amboinicus extract (PA-F4)
Strength: 2.5mg/g
Centella asiatica extract (S1)
Strength: 10mg/g
Detailed Information
Contraindications
**4\. Contraindications** FESPIXON is contraindicated in the patients who are hypersensitive to the ingredients of FESPIXON, including _Plectranthus amboinicus_, _Centella asiatica_ or excipients.
Indication Information
**2\. Indication** **Diabetic foot ulcer** Note: The clinical trial results are based on the subjects with non-ischaemic Wagner Grade 1 and Grade 2 chronic diabetic ulcers without active infection.